Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Recht

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia AS R Lentz, M Cerqueira, D Janic, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIIIM Recht, L Nemes, M Matysiak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 19, 2017
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyM Witkop, A Neff, T W Buckner, et al.
Proceedings of the International Society for Magnetic Resonance in Medicine ... Scientific Meeting and Exhibition. International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition|October 28, 2014
A 7-Tesla High Density Transmit with 28-Channel Receive-Only Array Knee CoilM Finnerty, X Yang, T Zheng, et al.
Blood Advances|November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor developmentB M Reipert, B Gangadharan, C J Hofbauer, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia AS R Lentz, M Cerqueira, D Janic, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIIIM Recht, L Nemes, M Matysiak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 19, 2017
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyM Witkop, A Neff, T W Buckner, et al.
Proceedings of the International Society for Magnetic Resonance in Medicine ... Scientific Meeting and Exhibition. International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition|October 28, 2014
A 7-Tesla High Density Transmit with 28-Channel Receive-Only Array Knee CoilM Finnerty, X Yang, T Zheng, et al.
Blood Advances|November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor developmentB M Reipert, B Gangadharan, C J Hofbauer, et al.
Pageof 5